{"id":"https://openalex.org/W2038587452","doi":"https://doi.org/10.1177/0269881103017001700","title":"The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat","display_name":"The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat","alternate_titles":[],"publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2038587452","doi":"https://doi.org/10.1177/0269881103017001700","mag":"2038587452","pmid":"https://pubmed.ncbi.nlm.nih.gov/12680740"},"language":"en","primary_location":{"id":"doi:10.1177/0269881103017001700","doi":"https://doi.org/10.1177/0269881103017001700","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881103017001700","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2038587452"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042599007","display_name":"Z. Abdul-Monim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139894009","display_name":"University of Bradford","ror":"https://ror.org/00vs8d940","country_code":"GB","type":"education","lineage":["https://openalex.org/I139894009"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Z. Abdul-Monim","raw_affiliation_strings":["The School of Pharmacy, The University of Bradford, Bradford, West Yorkshire","The School of Pharmacy, The University of Bradford, Bradford, West Yorkshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The School of Pharmacy, The University of Bradford, Bradford, West Yorkshire","institution_ids":["https://openalex.org/I139894009"]},{"raw_affiliation_string":"The School of Pharmacy, The University of Bradford, Bradford, West Yorkshire, UK","institution_ids":["https://openalex.org/I139894009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032606916","display_name":"Gavin P. Reynolds","orcid":"https://orcid.org/0000-0001-9026-7726","observed_orcids":["https://orcid.org/0000-0001-9026-7726"]},"institutions":[{"id":"https://openalex.org/I91136226","display_name":"University of Sheffield","ror":"https://ror.org/05krs5044","country_code":"GB","type":"education","lineage":["https://openalex.org/I91136226"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. P. Reynolds","raw_affiliation_strings":["The Department of Biomedical Science, The University of Sheffield, Sheffield, South Yorkshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Department of Biomedical Science, The University of Sheffield, Sheffield, South Yorkshire, UK","institution_ids":["https://openalex.org/I91136226"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049098570","display_name":"Joanna Caroline Neill","orcid":"https://orcid.org/0000-0002-2717-9739","observed_orcids":["https://orcid.org/0000-0002-2717-9739"]},"institutions":[{"id":"https://openalex.org/I139894009","display_name":"University of Bradford","ror":"https://ror.org/00vs8d940","country_code":"GB","type":"education","lineage":["https://openalex.org/I139894009"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. C. Neill","raw_affiliation_strings":["The School of Pharmacy, The University of Bradford, Bradford BD7 1DP, West Yorkshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The School of Pharmacy, The University of Bradford, Bradford BD7 1DP, West Yorkshire, UK","institution_ids":["https://openalex.org/I139894009"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5049098570"],"corresponding_institution_ids":["https://openalex.org/I139894009"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":2.6378,"has_fulltext":false,"cited_by_count":108,"citation_normalized_percentile":{"value":0.88936401,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"17","issue":"1","first_page":"57","last_page":"66"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ziprasidone","display_name":"ziprasidone","score":0.9900000095367432},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":0.9869999885559082},{"id":"https://openalex.org/keywords/reversal-learning","display_name":"reversal learning","score":0.5860000252723694},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.8100000023841858},{"id":"https://openalex.org/keywords/schizophrenia-model","display_name":"schizophrenia model","score":0.7039999961853027},{"id":"https://openalex.org/keywords/isolation-rearing","display_name":"isolation rearing","score":0.8759999871253967},{"id":"https://openalex.org/keywords/social-isolation","display_name":"social isolation","score":0.5450000166893005},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.7710000276565552},{"id":"https://openalex.org/keywords/food-deprivation","display_name":"food deprivation","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.8320630788803101},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.8244009017944336},{"id":"https://openalex.org/C2777270317","wikidata":"https://www.wikidata.org/wiki/Q205517","display_name":"Ziprasidone","level":4,"score":0.7491018772125244},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6786991357803345},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6382301449775696},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.5916762351989746},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.532808780670166},{"id":"https://openalex.org/C141421786","wikidata":"https://www.wikidata.org/wiki/Q1128897","display_name":"Prepulse inhibition","level":3,"score":0.47942274808883667},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4431261718273163},{"id":"https://openalex.org/C2775870346","wikidata":"https://www.wikidata.org/wiki/Q2554162","display_name":"Typical antipsychotic","level":5,"score":0.4368230998516083},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37824153900146484},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.33724427223205566},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.29169994592666626},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2735692858695984},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2651733458042145},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.2574300467967987},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.19897034764289856},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11416998505592346}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007274","descriptor_name":"Injections, Intraperitoneal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010622","descriptor_name":"Phencyclidine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012193","descriptor_name":"Reversal Learning","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012193","descriptor_name":"Reversal Learning","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D012934","descriptor_name":"Social Isolation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1177/0269881103017001700","doi":"https://doi.org/10.1177/0269881103017001700","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881103017001700","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:12680740","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12680740","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Comparative Study"},{"id":"pmh:oai:pure.qub.ac.uk/portal:publications/be327120-8944-4eae-a189-326387470eba","doi":null,"is_oa":false,"landing_page_url":"https://pure.qub.ac.uk/en/publications/be327120-8944-4eae-a189-326387470eba","pdf_url":null,"source":{"id":"https://openalex.org/S4306402319","display_name":"Research Portal (Queen's University Belfast)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126231945","host_organization_name":"Queen's University Belfast","host_organization_lineage":["https://openalex.org/I126231945"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Reynolds, G 2003, 'The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.', Journal of Psychopharmacology, vol. 17(1), no. 1, pp. 57-65.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320320138","display_name":"British Association for Psychopharmacology","ror":"https://ror.org/01ppg1t70"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W1591588997","https://openalex.org/W1964007889","https://openalex.org/W1969989982","https://openalex.org/W1972522199","https://openalex.org/W1973409122","https://openalex.org/W1973799461","https://openalex.org/W1974793630","https://openalex.org/W1975679961","https://openalex.org/W1980967004","https://openalex.org/W1982560775","https://openalex.org/W1985672723","https://openalex.org/W1989869372","https://openalex.org/W1990855494","https://openalex.org/W1994585641","https://openalex.org/W1999117408","https://openalex.org/W1999449017","https://openalex.org/W2003607000","https://openalex.org/W2006860551","https://openalex.org/W2012806030","https://openalex.org/W2017838119","https://openalex.org/W2024186806","https://openalex.org/W2025385931","https://openalex.org/W2027809421","https://openalex.org/W2028884770","https://openalex.org/W2030160228","https://openalex.org/W2031768762","https://openalex.org/W2033428309","https://openalex.org/W2035336511","https://openalex.org/W2038754388","https://openalex.org/W2049428499","https://openalex.org/W2050667075","https://openalex.org/W2056816990","https://openalex.org/W2056902640","https://openalex.org/W2059428006","https://openalex.org/W2060341999","https://openalex.org/W2060884332","https://openalex.org/W2061670307","https://openalex.org/W2064776106","https://openalex.org/W2066209808","https://openalex.org/W2084120702","https://openalex.org/W2087393099","https://openalex.org/W2089199123","https://openalex.org/W2093248761","https://openalex.org/W2095878413","https://openalex.org/W2097759310","https://openalex.org/W2106352416","https://openalex.org/W2117530671","https://openalex.org/W2128164348","https://openalex.org/W2128236630","https://openalex.org/W2140156016","https://openalex.org/W2145056060","https://openalex.org/W2150908000","https://openalex.org/W2158137297","https://openalex.org/W2318031042","https://openalex.org/W2397398976","https://openalex.org/W2412915137"],"related_works":["https://openalex.org/W2052781981","https://openalex.org/W1966316336","https://openalex.org/W1995194593","https://openalex.org/W2165378197","https://openalex.org/W2334692498","https://openalex.org/W1997347471","https://openalex.org/W2036273649","https://openalex.org/W2054002536","https://openalex.org/W2075232958","https://openalex.org/W2035601252"],"abstract_inverted_index":{"The":[0,47,71],"glutamate/N-methyl-D-aspartate":[1],"receptor":[2],"antagonist":[3],"phencyclidine":[4],"(PCP)":[5],"has":[6,38],"been":[7,39],"shown":[8],"to":[9,54,64,90,128,182,231],"induce":[10],"both":[11,154],"positive":[12],"and":[13,82,102,126,141,147,176],"negative":[14],"symptoms":[15],"of":[16,29,45,49,58,61,77,116,156,167,224,260],"schizophrenia,":[17],"as":[18,20,41],"well":[19],"cognitive":[21,66,93],"deficits,":[22],"thus":[23],"providing":[24],"a":[25,42,59,219,237],"relatively":[26],"valid":[27],"model":[28,44,65],"psychosis.":[30,46],"Isolation":[31],"rearing":[32],"from":[33,121],"weaning":[34,122],"in":[35,87,98,107,114,132,153,211,215,222,242],"the":[36,50,56,75,78,83,92,165,187,203,225,261,264],"rat":[37],"proposed":[40],"non-pharmacological":[43],"aim":[48],"present":[51,72],"study":[52,73],"was":[53,160,209,218,245],"explore":[55],"validity":[57],"combination":[60],"these":[62],"techniques":[63],"dysfunction":[67],"associated":[68],"with":[69,186,228,249],"schizophrenia.":[70],"evaluates":[74],"effects":[76],"novel":[79],"antipsychotic":[80,85],"ziprasidone":[81,198,229,250],"typical":[84],"haloperidol":[86,168,173],"their":[88],"ability":[89],"reverse":[91],"deficit":[94,241,265],"induced":[95],"by":[96,206,267],"PCP":[97,138,232,235],"isolation":[99,109],"reared":[100],"rats":[101],"social":[103,108,188,212],"controls.":[104],"Rats":[105],"housed":[106],"(n":[110,118],"=":[111,119],"25)":[112,120],"or":[113,263],"groups":[115,155],"five":[117],"were":[123,180],"food":[124,131],"deprived":[125],"trained":[127],"respond":[129],"for":[130],"an":[133],"operant":[134],"reversal":[135,150,226,239],"learning":[136,240],"paradigm.":[137],"at":[139],"1.0":[140],"1.5":[142],"mg/kg":[143],"(intraperitoneally,":[144],"i.p.)":[145,179,201],"significantly":[146,162],"selectively":[148],"impaired":[149],"task":[151,184,227],"performance":[152,223,259],"rats.":[157],"This":[158,208],"impairment":[159,204],"not":[161,252,257],"improved":[163],"following":[164,247],"coadministration":[166],"(0.05":[169],"mg/kg,":[170,178,200],"i.p.).":[171],"Higher":[172],"doses":[174],"(0.1":[175],"0.25":[177],"found":[181],"impair":[183],"performance,":[185],"animals":[189],"being":[190],"more":[191],"sensitive":[192],"than":[193],"isolation-reared":[194],"animals.":[195],"In":[196],"contrast,":[197],"(2.5":[199],"reversed":[202],"caused":[205],"PCP.":[207,268],"significant":[210],"animals,":[213],"while":[214],"isolates":[216],"there":[217],"non-significant":[220],"enhancement":[221],"compared":[230],"alone.":[233],"Thus,":[234],"produced":[236,266],"selective":[238],"rats,":[243],"which":[244],"ameliorated":[246],"treatment":[248],"but":[251],"haloperidol.":[253],"Rearing":[254],"conditions":[255],"did":[256],"influence":[258],"test":[262]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2038587452","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
